Evidence map›Paper›PMID 23812425›Full record

ArticleOncogene2014

KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer.

H Lu, L Hu, L Yu, X Wang, A M Urvalek, T Li, C Shen, D Mukherjee, S K Lahiri, M S Wason and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Kruppel-like Factors in Skeletal Physiology and Pathologies.International journal of molecular sciences · 2022
    Review
  8. Identification of Key Genes Associated with Brain Metastasis from Breast Cancer: A Bioinformatics Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  9. FAK in Cancer: From Mechanisms to Therapeutic Strategies.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Regulation of Krüppel-like factor 8 by the NEDD4 E3 ubiquitin ligase.American journal of translational research · 2019
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

H LuBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
L HuBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
L YuBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
X WangBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
A M UrvalekBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
T LiBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
C ShenBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
D MukherjeeBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
S K LahiriBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
M S WasonBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
J ZhaoBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
University of Central Florida · US

Funding

KLF8 Regulation of EMT Tumor MetastasisR01CA132977 · NCI · UNIVERSITY OF CENTRAL FLORIDA · PI ZHAO, JIHE · 2009 to 2014
$1.3M
NCI NIH HHS CA132977NCI NIH HHS R01 CA132977
6 · The paper itself

Abstract

Krüppel-like factor 8 (KLF8) regulates critical gene transcription associated with cancer. The underlying mechanisms, however, remain largely unidentified. We have recently demonstrated that KLF8 expression enhances the activity but not expression of matrix metalloproteinase-2 (MMP2), the target substrate of MMP14. Here, we report a novel KLF8 to MMP14 signaling that promotes human breast cancer invasion and metastasis. Using cell lines for inducible expression and knockdown of KLF8, we demonstrate that KLF8 promotes MMP14 expression at the transcriptional level. Knocking down KLF8 expression inhibited the breast cancer cell invasion both in vitro and in vivo as well as the lung metastasis in mice, which could be rescued by ectopic expression of MMP14. Promoter reporter assays and oligonucleotide and chromatin immunoprecipitations determined that KLF8 activates the human MMP14 gene promoter by both directly acting on the promoter and indirectly via promoting the nuclear translocation of β-catenin, the expression of T-cell factor-1 (TCF1) and subsequent activation of the promoter by the β-catenin/TCF1 complex. Inhibition of focal adhesion kinase (FAK) using pharmacological inhibitor, RNA interference or knockout showed that the cell surface presentation of active MMP14 downstream of KLF8 depends on FAK expression and activity. Taken together, this work identified novel signaling mechanisms by which KLF8 and FAK work together to promote the extracellular activity of MMP14 critical for breast cancer metastasis.

Indexed as

Animalsbeta CateninBreast NeoplasmsCell Line, TumorCell MembraneDisease Models, AnimalDisease ProgressionFemaleFocal Adhesion Kinase 1Gene ExpressionHepatocyte Nuclear Factor 1-alphaHeterograftsHumansKruppel-Like Transcription FactorsLung NeoplasmsMatrix Metalloproteinase 14beta CateninFocal Adhesion Kinase 1Hepatocyte Nuclear Factor 1-alphaHNF1A protein, humanKLF8 protein, humanKruppel-Like Transcription FactorsMatrix Metalloproteinase 14PTK2 protein, humanRepressor Proteins

Identifiers

PMID23812425
PMCPMC3929536
OpenAlexW2084178659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.